Affiliations
- PMID: 15578450
Evaluation of the efficacy and duration of immunity of a canine combination vaccine against virulent parvovirus, infectious canine hepatitis virus, and distemper virus experimental challenges
Omar Y Abdelmagid et al. Vet Ther. 2004 Fall.
Abstract
The results of this study confirmed that dogs vaccinated subcutaneously with a commercially available multivalent vaccine containing modified-live canine distemper virus, canine adenovirus type 2, canine parvovirus type 2b, and canine parainfluenza virus antigens were protected against sequential experimental challenge 55 to 57 months after initial vaccination given at 7 to 8 weeks of age. All 10 vaccinates were protected against clinical diseases and mortality following parvovirus and infectious canine hepatitis experimental infections. All vaccinates were protected against mortality and 90% against clinical disease following distemper challenge. These data support at least a 4-year duration of immunity for these three "core" fractions in the combination vaccine.
Similar articles
Three-year duration of immunity in dogs following vaccination against canine adenovirus type-1, canine parvovirus, and canine distemper virus.
Gore TC, Lakshmanan N, Duncan KL, Coyne MJ, Lum MA, Sterner FJ. Gore TC, et al. Vet Ther. 2005 Spring;6(1):5-14. Vet Ther. 2005. PMID: 15906266 Clinical Trial.
Canine viral vaccines at a turning point--a personal perspective.
Carmichael LE. Carmichael LE. Adv Vet Med. 1999;41:289-307. doi: 10.1016/s0065-3519(99)80022-6. Adv Vet Med. 1999. PMID: 9890023 Free PMC article. Review.
Canine parvovirus immunoprophylaxis: a review.
Moore DJ. Moore DJ. J S Afr Vet Assoc. 1983 Dec;54(4):259-64. J S Afr Vet Assoc. 1983. PMID: 6321731 Review.
Cited by
Isolation and genetic characterization of canine adenovirus type 2 from a domestic dog showing neurological symptoms.
Chander V, Sharma GK, Bhatt M, Nandi S, Mahajan S, Singh M, Mahendran K, Karikalan M, Pawde AM, Gupta V, Singh KP, Rajak KK, Gupta VK, Singh RK. Chander V, et al. Braz J Microbiol. 2021 Dec;52(4):2521-2528. doi: 10.1007/s42770-021-00540-0. Epub 2021 Jun 14. Braz J Microbiol. 2021. PMID: 34128211 Free PMC article.
In-vitro and in-vivo study of the interference between Rift Valley fever virus (clone 13) and Sheeppox/Limpy Skin disease viruses.
Safini N, Bamouh Z, Hamdi J, Jazouli M, Tadlaoui KO, El Harrak M. Safini N, et al. Sci Rep. 2021 Jun 11;11(1):12395. doi: 10.1038/s41598-021-91926-5. Sci Rep. 2021. PMID: 34117312 Free PMC article.
Evaluation of a Point-of-Care Test for Pre-Vaccination Testing to Detect Antibodies against Canine Adenoviruses in Dogs.
Bergmann M, Holzheu M, Zablotski Y, Speck S, Truyen U, Hartmann K. Bergmann M, et al. Viruses. 2021 Jan 26;13(2):183. doi: 10.3390/v13020183. Viruses. 2021. PMID: 33530411 Free PMC article.
Antibody Response to Canine Adenovirus-2 Virus Vaccination in Healthy Adult Dogs.
Bergmann M, Freisl M, Zablotski Y, Speck S, Truyen U, Hartmann K. Bergmann M, et al. Viruses. 2020 Oct 21;12(10):1198. doi: 10.3390/v12101198. Viruses. 2020. PMID: 33096809 Free PMC article.
Novel Genotype Definition and the First Epidemiological Investigation of Canine Adenovirus Type 2 in Dogs in Central China.
Ji J, Li W, Hu W, Xu X, Kan Y, Yao L, Bi Y, Xie Q. Ji J, et al. Front Vet Sci. 2020 Aug 19;7:534. doi: 10.3389/fvets.2020.00534. eCollection 2020. Front Vet Sci. 2020. PMID: 32974402 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
- The Lens - Patent Citations
Medical
- MedlinePlus Health Information